Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden

被引:24
作者
Kuokkanen, M
Butzow, R
Rasinperä, H
Medrek, K
Nilbert, M
Malander, S
Lubinski, J
Järvelä, I
机构
[1] Natl Publ Hlth Inst, Biomed Helsinki, Dept Mol Med, Helsinki, Finland
[2] Univ Helsinki, Dept Med Genet, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[4] Pomeranian Acad Med, Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[5] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[6] Univ Helsinki, Cent Hosp, Lab Serv HUSLAB, Mol Genet Lab, Helsinki, Finland
关键词
lactase persistence; epithelial ovarian cancer; C/T-13910; polymorphism; Finland; Poland; Sweden;
D O I
10.1002/ijc.21130
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian carcinoma is the fourth most common cause of cancer death in women. The cause and pathogenesis of this disease has remained obscure. Galactose, the hydrolyzing product of the milk sugar lactose, has been hypothesized to be toxic to ovarian epithelial cells and consumption of dairy products and lactase persistence has been suggested to be a risk factor for ovarian carcinoma. In adults, downregulation of lactase depends on a variant C/T-13910 at the 5' end of the lactase gene. To explore whether lactase persistence is related to the risk of ovarian carcinoma we determined the C/T-13910 genotype in a cohort of 782 women with ovarian carcinoma. The C/T-13910 genotype was defined by solid phase minisequencing from 327 Finnish, 303 Polish, 152 Swedish patients and 938 Finnish, 296 Polish and 97 Swedish healthy individuals served as controls. Lactase persistence did not associate significantly with increased risk for ovarian carcinoma in the Finnish odds ratio (OR = 0.77, 95% confidence interval [CI] = 0.57-1.05, p = 0.097), in the Polish (OR = 0.95, 95% Cl = 0.68-1.33, p = 0.75), or in the Swedish populations (OR = 1.63, 95% Cl = 0.65-4.08, p = 0.29). Our results do not support the hypothesis that lactase persistence increases the ovarian carcinoma risk. On the contrary, lactase persistence may decrease the ovarian carcinoma risk at least in the Finnish population. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 70 条
[1]  
Ahonen MH, 2000, INT J CANCER, V86, P40, DOI 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO
[2]  
2-E
[3]   DIAGNOSIS OF HYPOLACTASIA AND LACTOSE-MALABSORPTION [J].
AROLA, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 :26-35
[4]   Micronutrients and ovarian cancer: A case-control study in Italy [J].
Bidoli, E ;
La Vecchia, C ;
Talamini, R ;
Negri, E ;
Parpinel, M ;
Conti, E ;
Montella, M ;
Carbone, A ;
Franceschi, S .
ANNALS OF ONCOLOGY, 2001, 12 (11) :1589-1593
[5]   Lactose and benign ovarian tumours in a case-control study [J].
Britton, JA ;
Westhoff, C ;
Howe, GR ;
Gammon, MD .
BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1552-1555
[6]   REDUCTION IN OOCYTE NUMBER FOLLOWING PRENATAL EXPOSURE TO A DIET HIGH IN GALACTOSE [J].
CHEN, YT ;
MATTISON, DR ;
FEIGENBAUM, L .
SCIENCE, 1981, 214 (4525) :1145-1147
[7]   Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States) [J].
Cozen, W ;
Peters, R ;
Reichardt, JKV ;
Ng, W ;
Felix, JC ;
Wan, P ;
Pike, MC .
CANCER CAUSES & CONTROL, 2002, 13 (02) :113-120
[9]  
CRAMER DW, 1989, LANCET, V2, P66, DOI 10.1016/S0140-6736(89)90313-9
[10]  
CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717